ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,345.00
      0.02%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Celularity Inc (CELUW)

      7. Celularity Inc (CELUW) News

      CELUW

      Celularity (CELUW)

      Celularity Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CELUW
      DateTimeSourceHeadlineSymbolCompany
      2:15PMiHub NewswireFeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
      06/03/20248:38AMGlobeNewswire Inc.Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CELUWCelularity Inc
      05/24/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUWCelularity Inc
      05/24/20245:15PMGlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q FilingNASDAQ:CELUWCelularity Inc
      05/21/20249:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUWCelularity Inc
      05/15/20245:15PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CELUWCelularity Inc
      05/14/20249:15AMGlobeNewswire Inc.Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T TherapyNASDAQ:CELUWCelularity Inc
      04/22/20248:00AMGlobeNewswire Inc.Celularity Inc. to Host Investor and Analyst Research & Development DayNASDAQ:CELUWCelularity Inc
      04/19/20245:30PMGlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingNASDAQ:CELUWCelularity Inc
      04/18/20244:30PMGlobeNewswire Inc.Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024NASDAQ:CELUWCelularity Inc
      04/15/20248:00AMGlobeNewswire Inc.Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial ProductsNASDAQ:CELUWCelularity Inc
      04/08/20249:00AMGlobeNewswire Inc.Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental CellsNASDAQ:CELUWCelularity Inc
      03/26/20249:00AMGlobeNewswire Inc.Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3LNASDAQ:CELUWCelularity Inc
      03/20/20249:15AMGlobeNewswire Inc.Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular DystrophyNASDAQ:CELUWCelularity Inc
      03/14/20249:15AMGlobeNewswire Inc.Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE SummitNASDAQ:CELUWCelularity Inc
      03/12/20249:20AMGlobeNewswire Inc.Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World CongressNASDAQ:CELUWCelularity Inc
      03/07/20249:35AMGlobeNewswire Inc.Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental CellsNASDAQ:CELUWCelularity Inc
       Showing the most relevant articles for your search:NASDAQ:CELUW